Curaleaf is First to Florida Market With Sublingual Tablets

New Bites Designed for a Better Calibrated Dose are Launching at Curaleaf’s 28 Dispensaries Statewide

WAKEFIELD, Mass., July 30, 2020 /CNW/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, today announced the launch of Curaleaf Sublingual Tablets in Florida. These cube-shaped, berry-flavored bites will provide the state’s medical patients with a discreet, sugar-free yet fruity alternative form of medication.

Curaleaf’s new Sublingual Tablets, which will be in 30-piece jars, contain 5mg of high-quality cannabis oil per piece, which allows patients to manage their treatment plan with confidence and ease. Each bite, which is made to be ingested orally or sublingually, is translucent in color and features a refreshing “Arctic Berry” flavor. The new product will be sold at all of the Company’s 28 operating dispensaries in Florida with a phased roll-out between August 8th – August 20th. Limited quantities will be released to pre-existing loyalty patients beginning tomorrow, July 30th. For more information on the product roll-out cadence, please visit

“The demand for alternative cannabis form functions in Florida has been mounting for years, and we are thrilled to offer our

Read More


Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Scroll to Top